Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Faron Pharmaceuticals (FARN) Share Price

Price 42.00p on 30-07-2026 at 17:55:06
Change -1.00p -2.33%
Buy 44.00p
Sell 40.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Sell 2,100.00 at 41.50p
Day's Volume: 64,569
Last Close: 42.00p
Open: 43.00p
ISIN: FI4000153309
Day's Range 42.00p - 43.00p
52wk Range: 38.70p - 240.00p
Market Capitalisation: £85.21m
VWAP: 41.75051p
Shares in Issue: 202.88m

Sector: Medicine and Biotech

Listed In: FTSE AIM 100, FTSE AIM All-Share,

Faron Pharmaceuticals (FARN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 2,100 41.50p Ordinary
 16:47:44 - 30-Jul-26
Buy* 106 42.387p Ordinary
 16:26:07 - 30-Jul-26
Buy* 1,120 42.40p Ordinary
 16:24:53 - 30-Jul-26
Buy* 365 44.00p Ordinary
 16:16:51 - 30-Jul-26
Sell* 23,714 41.00p Ordinary
 16:16:47 - 30-Jul-26
Sell* 1,000 42.48p Ordinary
 15:54:22 - 30-Jul-26
Unknown* 2,336 42.50p Ordinary
 15:21:51 - 30-Jul-26
Unknown* 71 42.50p Ordinary
 15:09:24 - 30-Jul-26
Buy* 3 44.00p SI Trade
 14:44:31 - 30-Jul-26
Sell* 3,900 41.25p Ordinary
 14:02:55 - 30-Jul-26
See more Faron Pharmaceuticals trades

Faron Pharmaceuticals (FARN) Share Price History

Time period:
to
Date Open High Low Close Volume
30th Jul 2026 (Thu) 43.00 43.00 42.00 42.00 64,569
29th Jul 2026 (Wed) 43.00 43.40 43.00 43.00 148,934
28th Jul 2026 (Tue) 43.00 43.80 41.50 43.00 310,151
27th Jul 2026 (Mon) 40.50 43.80 41.50 41.50 277,655
24th Jul 2026 (Fri) 41.00 41.00 40.50 40.50 147,703
23rd Jul 2026 (Thu) 41.00 41.00 41.00 41.00 27,885
22nd Jul 2026 (Wed) 40.50 41.00 40.50 41.00 16,235
21st Jul 2026 (Tue) 40.50 40.50 40.50 40.50 6,814
20th Jul 2026 (Mon) 41.00 41.00 40.50 40.50 47,066
17th Jul 2026 (Fri) 41.00 41.00 41.00 41.00 45,407
16th Jul 2026 (Thu) 42.00 42.00 41.00 41.00 46,915
15th Jul 2026 (Wed) 42.00 42.00 42.00 42.00 15,828
14th Jul 2026 (Tue) 41.50 42.00 41.50 42.00 95,977
13th Jul 2026 (Mon) 41.50 41.50 41.50 41.50 144,987
10th Jul 2026 (Fri) 41.50 41.50 41.50 41.50 39,662
9th Jul 2026 (Thu) 41.00 41.50 41.00 41.50 29,176
8th Jul 2026 (Wed) 41.00 41.00 41.00 41.00 26,588
7th Jul 2026 (Tue) 41.00 41.00 41.00 41.00 32,685
6th Jul 2026 (Mon) 42.00 42.00 41.00 41.00 50,250
3rd Jul 2026 (Fri) 41.00 42.00 41.00 42.00 65,101
2nd Jul 2026 (Thu) 41.00 41.00 41.00 41.00 559
1st Jul 2026 (Wed) 41.00 41.00 41.00 41.00 37,577
See more Faron Pharmaceuticals price history

Faron Pharmaceuticals (FARN) Regulatory News

Date Source Headline
27th Jul 2026 7:00 am MFN Faron Pharmaceuticals: Inside Information: Faron announces encouraging first overall survival data from frontline higher-risk (HR) MDS patients in the BEXMAB phase 1/2 trial
24th Jul 2026 7:00 am MFN Faron Pharmaceuticals: FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY
1st Jul 2026 11:00 am MFN Faron Pharmaceuticals: Faron Pharmaceuticals Ltd: Grant of Options
22nd Jun 2026 2:00 pm MFN Faron Pharmaceuticals: FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY
17th Jun 2026 2:30 pm MFN Faron Pharmaceuticals: FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY
17th Jun 2026 7:00 am MFN Faron Pharmaceuticals: FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY
15th Jun 2026 4:00 pm MFN Faron Pharmaceuticals: FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY
11th Jun 2026 3:05 pm MFN Faron Pharmaceuticals: FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY
11th Jun 2026 3:00 pm MFN Faron Pharmaceuticals: Faron Pharmaceuticals Ltd: Registration of Treasury Shares
10th Jun 2026 5:45 pm MFN Faron Pharmaceuticals: FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY
See more Faron Pharmaceuticals regulatory news

Faron Pharmaceuticals (FARN) Share News

IN BRIEF: Faron Pharmaceuticals fined EUR30,000 by Nasdaq Helsinki

5th Jun 2026 12:37

Faron Pharmaceuticals Ltd - Turku, Finland-based cancer drug developer - Says the Disciplinary Committee of Nasdaq Helsinki Ltd has imposed an EUR30,000 fine over breaches in 2024. The committee found that Faron breached the Nasdaq First North Growth Rulebook for Issuers of Shares, regarding "the obligation to disclose inside information without undue delay in certain matters". It also breached "good securities market practise" regarding "certain public statements made in a media interview". Faron notes that the committee dismissed two alleged breaches, including "importantly," the allegation that Faron had not organised its administration in the manner required for listed companies. Read More

UK shareholder meetings calendar - next 7 days

27th Apr 2026 12:17

Read More

WINNERS & LOSERS: James Cropper sees earnings up; Block sells stake

14th Apr 2026 11:37

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday. Read More

WINNERS & LOSERS: Secure Trust holds provision; Steppe sales rise

10th Apr 2026 10:11

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday. Read More

IN BRIEF: Faron Pharmaceuticals hires Heikki Jouttijarvi as CTO

27th Mar 2026 07:00

Faron Pharmaceuticals Ltd - Turku, Finland-based cancer drug developer - Hires Heikki Jouttijarvi as chief technical officer, saying he has decades of experience in biopharma manufacturing, supply chain management and commercial operations. Chief Executive Officer Juho Jalkanen says: "His wealth of experience with commercial operations, manufacturing and supply chain management with late-stage and approved drugs is incredibly valuable for us as we progress with bexmarilimab to the announced phase IIb trial in higher-risk myelodysplastic syndromes". Bexmarilimab is an investigational immunotherapy designed to overcome resistance to existing treatments, among others. Myelodysplastic syndromes are a type of blood cancer. Read More

See more Faron Pharmaceuticals news
FTSE 100 Latest
Value10,897.27
Change-11.14

Login to your account

Forgot Password?

Not Registered